Literature DB >> 22977359

Dyslipidaemic pattern of patients with type 2 diabetes mellitus.

Eid Mohamed1, Mafauzy Mohamed, Faridah Abdul Rashid.   

Abstract

The aim of the study was to define dyslipidaemic pattern among type 2 diabetic patients using American Diabetes Association guidelines for the classification of lipoprotein concentrations into CVD risk categories. The total number screened was 211 type 2 diabetic patients who were on treatment between 2001 - 2002 for diabetes at the Outpatient Diabetes Clinic in HUSM Kubang Kerian. Fasting venous blood samples were analysed for plasma glucose, glycated hemoglobin and serum lipids. Type 2 diabetic patients with high, borderline, and low risk LDL cholesterol level were 62 %, 25 %, and 10 %, respectively. There were 26 % patients in the high risk HDL cholesterol group, 31 % were in the borderline risk group, and 43 % were in the low risk group. Only 3 % and 25 % of patients had triglycerides concentration in the high and borderline risk categories, respectively, but 72 % had low risk triglycerides levels. More female and younger subjects than men and older subjects had HDL cholesterol in high and borderline risk categories. The percentages of patients with triglycerides values at high and borderline high risk category were higher in poor and acceptable glycaemic control groups than good glycaemic control group. The most prevalent dyslipidaemia pattern was an isolated LDL cholesterol increase, which was observed in 35 % of the patients. The second most common pattern of dyslipidaemia was a combination of LDL cholesterol above goal with HDL cholesterol below target, which was observed in 30 % patients. Patients with established dyslipidaemia will require advice regarding diet, exercise and improvement in glycaemic control. An active strategy of early detection and drug treatment for dyslipidaemia is needed for type 2 diabetic patients.

Entities:  

Keywords:  Dyslipidaemia; Type 2 Diabetes

Year:  2004        PMID: 22977359      PMCID: PMC3438150     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  11 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2002-01       Impact factor: 19.112

3.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

4.  Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey.

Authors:  P Primatesta; N R Poulter
Journal:  BMJ       Date:  2000-11-25

5.  Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Authors:  V Manninen; L Tenkanen; P Koskinen; J K Huttunen; M Mänttäri; O P Heinonen; M H Frick
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

6.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome.

Authors:  S M Grundy
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

7.  LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.

Authors:  B V Howard; D C Robbins; M L Sievers; E T Lee; D Rhoades; R B Devereux; L D Cowan; R S Gray; T K Welty; O T Go; W J Howard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

8.  The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Authors:  C B Cook; D M Erdman; G J Ryan; K J Greenlund; W H Giles; D L Gallina; I M El-Kebbi; D C Ziemer; K L Ernst; V G Dunbar; L S Phillips
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

9.  Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.

Authors:  M Laakso; S Lehto; I Penttilä; K Pyörälä
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

10.  Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.

Authors:  P Koskinen; M Mänttäri; V Manninen; J K Huttunen; O P Heinonen; M H Frick
Journal:  Diabetes Care       Date:  1992-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.